Cancer Diagnostics

1 Molecular Diagnostics in Neoplastic Hematopathology Daniel A. Arber; 2 HER2 and Topoisomerase II[alpha] in Breast Carcinoma Kenneth J. Bloom; 3 Study of Sentinel Lymph Nodes for Staging Malignant Neoplasms Alice A. Roberts and Alistair J. Cochran; 4 Prostate Cancer Markers: From Discovery to the Clinic Judith A. Finlay, Stephen D. Mikolajczyk, Thomas M. Pribyl, R. Bruce Wallace, and Harry G. Rittenhouse; 5 Diagnosis of Ataxia-Telangiectasia: ATM Mutations Associated with Cancer Midori Mitui, Shareef A. Nahas, Helen H. Chun, and Richard A. Gatti; 6 Microsatellite Alterations as Diagnostic and Prognostic Markers in Patients with Cancer Bret Taback and Dave S. B. Hoon; 7 Chromosomal and Molecular Cytogenetic Assays for Evaluation of Human Tumors. Peter C. Hu, Armand B. Glassman, and Vicki L. Hopwood; 8 New Insights and Future Advances in Cancer Diagnostics: Limitations of Conventional Tumor Markers Yasushi Kasahara and Yutaka Tsukada; 9 MHC Tetramers: A Tool for Direct Ex Vivo Detection and Enumeration of Tumor Specific Cytotoxic T Cells Kristine Kuus-Reichel, Jennie Chang, Ferdynand Kos, and Charles T. Nugent; 10 Serum Tumor Marker Test Profile in Testicular Germ Cell Tumors Frank J. Liu, Robert M. Nakamura, C. Howard Tseng, and Kevin S. Liu; 11 A Marker for Early Diagnosis of Lung Cancer: The Heterogeneous Nuclear Ribonucleoprotein A2/B1 (hnRNP A2/B1) Jordi Tauler, Alfredo Martinez, and James L. Mulshine; 12 New Applications of Flow Cytometry in Cancer Diagnosis and Therapy Sophie Song and Faramarz Naeim; 13 The Changing Role of the Pathologist in the Management of the Cancer Patient Raymond B. Nagle; 14 General Considerations in the Use and Application of Laboratory Tests for the Evaluation of Cancer Robert M. Nakamura and Wayne W. Grody; 15 Autoantibodies, Autoimmunity, and Cancers: Markers for Identification of Early Stages of Tumors Robert M. Nakamura and Eng M. Tan; 16 Molecular Techniques in Cancer Diagnosis and Management Jeffrey S. Ross, Karen Gray, Rebecca Mosher, and James Stec; 17 DNA Repair Defects in Cancer Ramune Reliene and Robert H. Schiestl; 18 Genetic Counseling for Hereditary Cancer Predisposition Testing Joyce L. Seldon and Patricia A. Ganz; 19 Types of Circulating Tumor Markers and Their Clinical Applications James T. Wu; 20 Identification of Risk Factors for Early Neoplasm James T. Wu; 21 Emerging Circulating Tumor Markers James T. Wu; 22 Recent Advances in Molecular Classification and Prognosis of Colorectal Cancer Tsung-Teh Wu and Asif Rashid; Molecular Diagnostics in Neoplastic. HER2 and Topoisomerase IIa in Breast Carcinoma Study of Sentinel Lymph Nodes for Staging Malignant. Prostate Cancer Markers: From Discovery to the Clinic. Diagnosis of Ataxia-Telangiectasia: ATM Mutations Associated With Cancer. Microsatellite Alterations as Diagnostic and Prognostic Markers in Patients with Cancer. Chromosomal and Molecular Cytogenetic Assays for Evaluation of Human Tumors. New Insights and Future Advances in Cancer Diagnostics: Limitations of Conventional Tumor Markers. MHC Tetramers: A Tool for Direct Ex Vivo Detection and Enumeration of Tumor Specific Cytotoxic T Cells. Serum Tumor Marker Test Profile in Testicular Germ Cell Tumors. A Marker for Early Diagnosis of Lung Cancer: The Heterogeneous Nuclear Ribonucleoprotein A2/B1 (hnRNP A2/B1). New Applications of Flow Cytometry in Cancer Diagnosis and Therapy. The Changing Role of the Pathologist in the Management of the Cancer Patient. General Considerations in the Use and Application of Laboratory Tests for the Evaluation of Cancer. Autoantibodies, Autoimmunity, and Cancers: Markers for Identification of Early Stages of Tumors. Molecular Techniques in Cancer Diagnosis and Management. DNA Repair Defects in Cancer. Genetic Counseling for Hereditary Cancer Predisposition Testing Types of Circulating Tumor Markers and Their Clinical Applications. Identification of Risk Factors for Early Neoplasm. Emerging Circulating Tumor Markers. Recent Advances in Molecular Classification and Prognosis of Colorectal Cancer